Watchlist Price Alert

NRx Pharmaceuticals Inc. (NRXP)

NASDAQ: NRXP · Real-Time Price · USD

3.49

0.05 (1.45%)

At close: Jun 16, 2025, 3:59 PM

3.43

-1.69%

After-hours: Jun 16, 2025, 07:42 PM EDT

1.45% (1D)

Bid	3.43
Market Cap	60.32M
Revenue (ttm)	4K
Net Income (ttm)	-24.11M
EPS (ttm)	-1.96
PE Ratio (ttm)	-1.78
Forward PE	4.88
Analyst	Buy

Ask	3.5
Volume	185,737
Avg. Volume (20D)	255,850
Open	3.53
Previous Close	3.44
Day's Range	3.44 - 3.58
52-Week Range	1.10 - 6.01
Beta	1.55

About NRXP

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol NRXP

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for NRXP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

4 months ago

+24.56%

NRx Pharmaceuticals shares are trading higher afte... Unlock content with Pro Subscription

5 months ago

+30.48%

NRX Pharmaceuticals shares are trading higher after the company announced it will acquire Dura Medical with HOPE Therapeutics. Additionally, the company signed a binding term sheet with HOPE with $27 million to fund further acquisitions and pharmaceutical operations.

News

5 days ago · https://www.defenseworld.net

Squarepoint Ops LLC Makes New Investment in NRx Pharmaceuticals, Inc. (NASDAQ:NRXP)

Squarepoint Ops LLC purchased a new position in NRx Pharmaceuticals, Inc. (NASDAQ:NRXP – Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchang...

1 month ago · seekingalpha.com

NRx Pharmaceuticals, Inc. (NRXP) Q1 2025 Earnings Call Transcript

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP ) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Matthew Duffy – Chief Business Officer Jonathan Javitt – Founder, Chairman, and C...

2 months ago · zacks.com

Here's Why NRx Pharmaceuticals (NRXP) Is a Great 'Buy the Bottom' Stock Now

NRx Pharmaceuticals (NRXP) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions coul...

3 months ago · seekingalpha.com

NRx Pharmaceuticals, Inc. (NRXP) Q4 2024 Earnings Call Transcript

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP ) Q4 2024 Earnings Conference Call March 17, 2025 8:30 AM ET Company Participants Matthew Duffy - Chief Business Officer Jonathan Javitt - Founder, Chairman and ...